Position in ROIV
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$114,401
+$112,188 QoQ
Shares Held
4,130
+3949.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quent Capital, LLC holds $1,203,336 across 36 Biotechnology names. ROIV ranks #3 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
366 | $282,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
563 | $251,402 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
4,130 | $114,401 | |
| 4 | INSM |
INSMED Inc
|
616 | $100,728 | |
| 5 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
30,000 | $84,900 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
307 | $58,038 | |
| 7 | INCY |
Incyte Corp
|
396 | $37,271 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
67 | $22,168 |
All Filings in ROIV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,401 | 4,130 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,213 | 102 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,543 | 102 | Shares | Sole | 2025-10-27 | |
| 2025-03-31 | $1,029 | 102 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $1,443 | 122 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $2,308 | 200 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $2,114 | 200 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $1,665 | 158 | Shares | Sole | 2024-06-28 | |
| 2023-12-31 | $22 | 2 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||